We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
SI
1
Sofinnova Investments
California
$3.84M
DTC
2
Deep Track Capital
Connecticut
$3.41M
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$3.26M +$880K +503,466 +19%
RSCM
4
Rock Springs Capital Management
Maryland
$3.24M +$487K +278,409 +10%
VA
5
VR Adviser
New York
$2.85M
PBPIA
6
Pivotal bioVenture Partners Investment Advisor
California
$2.79M
NMC
7
NEA Management Company
Maryland
$2.56M -$11.7K -6,690 -0.3%
CA
8
CHI Advisors
New York
$2.32M +$365K +208,599 +10%
SFM
9
Sphera Funds Management
Israel
$1.71M +$786K +450,000 +38%
Vanguard Group
10
Vanguard Group
Pennsylvania
$1.41M +$977 +559 +0%
AAA
11
Affinity Asset Advisors
New York
$525K +$874K +500,000 New
BlackRock
12
BlackRock
New York
$448K -$3.86K -2,207 -0.5%
Millennium Management
13
Millennium Management
New York
$313K +$223K +127,752 +75%
LCM
14
Laurion Capital Management
New York
$285K
Renaissance Technologies
15
Renaissance Technologies
New York
$272K +$181K +103,500 +67%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$244K -$977 -559 -0.2%
MB
17
MPM BioImpact
Massachusetts
$242K -$753K -430,644 -65%
OMC
18
Overbrook Management Corp
New York
$230K +$262K +150,000 +216%
UOC
19
UBS O'Connor
Illinois
$148K -$43.5K -24,875 -15%
BCM
20
Bridgeway Capital Management
Texas
$140K
State Street
21
State Street
Massachusetts
$80.2K
Northern Trust
22
Northern Trust
Illinois
$48.2K +$9.86K +5,639 +14%
State of Wisconsin Investment Board
23
State of Wisconsin Investment Board
Wisconsin
$39.6K -$19.4K -11,100 -23%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$21.3K
PA
25
Parallel Advisors
California
$20.9K +$34.7K +19,867 New